TheProfitWatch

QURE - uniQure N.V.

Day 1m 10m 60m PreMarket Market AfterHours Gap
27.45 0.48 (1.75%) 0.04 (0.14%) -0.15 (-0.53%) -0.3 (-1.06%) -0.14 (-0.51%) 0.15 (0.54%) 0.18 (0.65%) -0.39 (-1.41%)

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.69
Diluted EPS:
-0.69
Basic P/E:
-40.4783
Diluted P/E:
-40.4783
RSI(14) 1m:
42.73
VWAP:
27.91
RVol:

Events

Period Kind Movement Occurred At

Related News